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Abstract The Swedish OCTO and NONA immune
longitudinal studies were able to identify and confirm
an immune risk profile (IRP) predictive of an increased
2-year mortality in very old individuals, 86–94 years of
age. The IRP, was associated with persistent cytomega-
lovirus infection and characterized by inverted CD4/
CD8 ratio and related to expansion of terminally differ-
entiated effector memory T cells (TEMRA phenotype).
In the present HEXA immune longitudinal study, we
have examined a younger group of elderly individuals
(n0424, 66 years of age) in a population-based sample
in the community of Jönköping, Sweden, to examine the
relevance of findings previously demonstrated in the
very old. Immunological monitoring that was conducted
included T cell subsets and CMV-IgG and CMV-IgM
serology. The result showed a prevalence of 15 % of
individuals with an inverted CD4/CD8 ratio, which was
associated with seropositivity to cytomegalovirus and
increases in the level of TEMRA cells. The proportion
of individuals with an inverted CD4/CD8 ratio was
significantly higher in men whereas the numbers of
CD3+CD4+ cells were significantly higher in women.
In conclusion, these findings are very similar to those
previously found by us in the Swedish longitudinal
studies, suggesting that an immune profile previously
identified in the very old also exists in the present
sample of hexagenerians. Therefore, it will be important
to examine clinical parameters, including morbidity and
mortality, to assess whether the immune profile also is a
risk profile associated with higher mortality in this sam-
ple of hexagenerians.
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Introduction
The mean lifespan for humans in industrialized
countries is steadily increasing, and the very old
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constitute the fastest growing age segment with com-
promised health and increased need for advanced health
care. Dysfunction of the immune system is commonly
assumed to be responsible for the increased susceptibil-
ity to infectious disease and reduced response to vacci-
nation in old people (Pawelec et al. 2010).
In the Swedish OCTO Immune Longitudinal study
(referred to here as OCTO), we identified an immune
risk profile (IRP) among very old individuals (85+)
selected on the basis of individuals being at good health.
Cluster analysis of immune data that was composed of
the proliferative response to the mitogen Concanavalin
A (ConA), and the percentages of CD3, CD4, CD8, and
CD19 positive cells, identified an IRP predictive of 2-
year mortality. The IRP cluster was characterized by
high levels of CD8 and low levels of CD4 and CD19
together with a decreased response to ConA (Ferguson
et al. 1995). This combination of immune parameters
was later designated as the immune risk profile (Pawelec
et al. 2001). Furthermore, the studies have shown that
persistent cytomegalovirus (CMV) infection as well as
the accumulation of lately differentiated CD8+CD28
−CD27− cells are likely to be associated with the IRP
(Olsson et al. 2000; Reker-Hadrup et al. 2006).
The results from the OCTO provided the background
to the NONA immune longitudinal study (referred to
here as NONA) in a sample of very old individuals (86
+) without excluding individuals due to compromised
health (Wikby et al. 2002). Here, IRP was identified
using the inverted CD4/CD8 ratio, since this marker was
found to be significantly associated with the risk profile.
The NONA confirmed the findings obtained in the
OCTO. Moreover, it showed that IRP was independent
of the overall health status in the NONA sample, in
which as much as 63 % comprised of frail individuals
(Wikby et al. 2002; Nilsson et al. 2003).
In an attempt to expand these results to the whole
lifespan of an adult, a retrospective study was conducted
using another population-based study, Kristianstad Sur-
vey (KRIS), together with the OCTO and NONA stud-
ies (Wikby et al. 2008). Notably, the prevalence of a
CD4/CD8 ratio less than 1 increased from about 8 % in
age span of 20–59 years to about 16 % in ages between
60 and 94. The mortality rate in individuals with an
inverted CD4/CD8 ratio was increased above the age
of 60 years. In addition, the proportion of individuals
with an inverted CD4/CD8 ratio was significantly
higher in men than in women. Unfortunately, the KRIS
study did not provide data on CMVinfection or on lately
differentiated CD8+CD28−CD27− cells that are associ-
ated with the IRP.
The aim of the present study was to further test the
results obtained in the KRIS, to assess whether the IRP
might be relevant among younger elderly similarity
with previous findings in the very old. Here, we report
data from a new Swedish HEXA immune longitudinal
study of individuals with 66 years of age. The study
investigates the prevalence of individuals with an
inverted CD4/CD8 ratio as well as data on T and B
cell subsets, CMV infection, and gender, which were
previously found to be associated with an IRP in very
old individuals.
Materials and methods
The Swedish HEXA study subjects
A population-based sample of 66-year-old individuals
with no exclusion criteria formed the framework of this
study. Census data collected from January 2009 was
used to identify these hexagenerians (referred here as
HEXA-1 individuals) permanently residing within the
municipality of Jönköping, located in the south-central
part of Sweden. From 1,310 66-year-old potential par-
ticipants, 655 were randomly selected and invited.
Blood samples were consecutively collected until re-
ceiving 424 participants which was previously decided
based on power analysis. A non-proportional sampling
procedure between men and women was used. Of the
424 participants, 227 were women (53.5 %) and 197
men (46.5 %). Every participant answered a question-
naire concerning diseases in the past or present, ongoing
medication, exercise, and smoking.
In order to establish a deeper analysis of the immune
profile that was obtained from the screening of individ-
uals fromHEXA-1, a new random selection of HEXA-1
individuals was performed. HEXA-1 participants were
invited to HEXA-2 based on the results from HEXA-1.
Fifty individuals with a CD4/CD8 ratio less than 1 and
101 individuals with a CD4/CD8 ratio more than 1.2
comprised the sample of HEXA-2.
Blood and cell preparations from HEXA-1
and HEXA-2 individuals’
Venous blood samples were drawn at health care cen-
ters in the municipality of Jönköping. For HEXA-1
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individuals, three EDTA vacutainer tubes (BD Bio-
sciences, Stockholm Sweden) of 3 ml whole blood
were drawn from each subject between 9 and 12 am
and were analyzed within 24 h. One tube was used for
flow cytometric analysis. The other two tubes were
prepared by centrifugation at 1,500×g for 10 min.
Plasma was transferred to separate micro tubes
(VWR International, Stockholm, Sweden) and stored
at −70 °C for IgG and IgM serology analysis. For
HEXA-2 individuals, one Na-heparin vacutainer tube
of 4 ml was drawn. The blood samples were used for
flow cytometric analysis.
Flow cytometric analysis
In HEXA-1, a flow cytometry panel was used to
define major lymphocyte populations. Data was
acquired using a FACSCanto flow cytometer (BD
Biosciences, San José, CA), and the Diva software
(BD Biosciences) was used to calculate absolute
numbers as well as percentages of T cell subsets.
Briefly, 50 μl of whole blood was stained with
5 μl of an antibody cocktail containing the follow-
ing antibodies: CD3 FITC, CD4 PE-Cy7, CD8
APC-Cy7, CD16 PE+CD56 PE, CD19 APC, and
CD45 PerCP-Cy5.5 (BD Biosciences). After
15 min incubation in room temperature in the
dark, 450 μl of BD FACSTM lysing solution was
added. The BD TrueCount™ tubes were used for
accurate calculation of the lymphocyte numbers.
For HEXA-2 individuals, an extended panel was
used with fluorochome label antibodies against
surface antigen on following lymphocyte subsets:
CD3 APC H7, CD4 FITC, CD8 FITC, CD27
APC, CD28 PerCP-Cy5.5, and CCR7 PE (BD
Biosciences).
Cytomegalovirus serology
Plasma from all individuals in HEXA-1 was analyzed
for IgG and IgM antibodies against CMV according to
the manufacturer’s instructions (Zeus Scientific,
Branchburg, NJ, USA). Absorbance was measured and
an optical density (OD) ratio was calculated. OD values
was interpreted as negative (<0.90), equivocal (0.91–
1.09) and positive (>1.10).
Data analysis
Statistical analyses were conducted by using SPSS 14.
Student’s t test was used for comparison of indepen-
dent groups. The chi-square test was used for analyz-
ing the subgroups of CD4/CD8 ratio, CMV carrier
status, and gender.
Results
Prevalence of individuals with an inverted
CD4/CD8 ratio and frequency of T and B cell
subsets for HEXA-1 individuals with CD4/CD8
ratio less than or greater than 1
Sixty-two individuals out of 424 (14.6 %) had a CD4/
CD8 ratio less than 1. The percentages and numbers of T
and B cells are shown in Table 1. Individuals with a CD4/
CD8 ratio less than 1 showed a significant increase in the
percentages and numbers of CD3+CD8+ cells and de-
creased percentages and numbers of CD3+CD4+ cells.
Individuals with CD4/CD8 ratio less than 1 also showed
a significant decrease in the percentage of CD19 B cells.
Table 1 Proportions (%) and
numbers (per μl) of T and B cell
subsets in 66-year-old individu-
als categorized by their CD4/
CD8 ratio
aMean ± SE
Cell subset CD4/CD8 <1 CD4/CD8 >1 p<
n062 n0362
CD3 (%) 76.3±1.2a 71.4±0.5 0.001
CD4 (%) 30.6±0.7 46.6±0.4 0.001
CD8(%) 40.6±1.1 20.7±0.4 0.001
CD19 (%) 8.5±0.7 10.7±0.2 0.01
CD3 (cells/μl) 2,018±85 1,542±27 0.001
CD4 (cells/μl) 807±36 1,004±18 0.001
CD8 (cells/μl) 1,083±54 451±12 0.001
CD19 (cells/μl) 213±18 232±7 NS
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Prevalence of CMV IgG and IgM antibodies
and relation to CD4/CD8 ratio
Overall, 327 out of 424 (77 %) were CMV-IgG positive
and 24 (5.6 %) were CMV-IgM positive. CMV-IgG was
significantly more common in individuals with CD4/
CD8 ratio less than 1, and for CMV-IgM, there was a
tendency in the same direction (Table 2). In CMV-IgG
positive individuals, the levels of CMV-IgG antibodies
were significantly higher in those with a CD4/CD8 ratio
less than 1 (3.3±1.0, n014) compared to those with a
ratio greater than 1 (3.0±0.9 n0271, p<0.05).
Proportions and absolute numbers of T and B cell
subsets for CMV-IgG positive and negative
individuals
There were significant increases in the percentages and
numbers of CD3+ and CD3+CD8+ cells and decreases
in CD3+CD4+ cells in CMV-IgG positive individuals
compared with negative individuals (Table 3). CMV-
IgG positive individuals also showed a significantly
lower CD4/CD8 ratio compared with the CMV-IgG
negative individuals.
Proportions and absolute numbers of T and B cell
subsets for CMV-IgG positive and negative
individuals with a CD4/CD 8 ratio less than 1
CMV-IgG positive individuals showed significantly
higher numbers of CD3+, CD4+, and CD8+ cells as
compared with negative individuals (Table 4). The
CMV-IgG positive individuals also showed a lower
CD4/CD8 ratio, although the difference between the
groups did not reach statistical significance.
Proportions (%) of naïve and terminally differentiated
effector memory CD3+CD8+CD28−CCR7−CD45RA
+cells related to CD4/CD8 ratio and CMV-IgG status
in HEXA-2 individuals
The percentage of terminally differentiated effector
memory (TEMRA) cells in individuals with a CD4/
Table 2 Chi-square analysis of relationships of cytomegalovi-
rus IgG and IgM antibodies in 66-year-old individuals catego-
rized by their CD4/CD8 ratio
CMV antibody
status
CD4/CD8 <1 CD4/CD8 >1 p<
n062 n0362
IgG
+ 56 (90.3)a 271 (74.9) 0.05
+/−b 0 (0.0) 2 (0.6)
− 6 (9.7) 89 (24.6)
IgM
+ 5 (8.1) 19 (5.2) NS
+/−b 3 (4.8) 7 (1.9)
− 54 (87.1) 336 (92.8)
a No (% within CD4/CD8 subgroup)
b Equivocal
Table 3 Proportions (%) and numbers (per μl) of T and B cell
subsets in 66-year-old CMV-IgG positive and negative
individuals
Cell subset CMV-IgG p<
Positive Negative
n0327 n095
CD3 (%) 72.9±0.5a 69.5±1.0 0.01
CD4 (%) 43.4±0.5 47.3±0.4 0.01
CD 8 (%) 25.5±0.6 17.2±0.9 0.001
CD 19 (%) 10.2±0.3 10.9±0.5 NS
CD 3 (cells/μl) 1,697±32 1,326±39 0.001
CD 4 (cells/μl) 997±20 897±29 0.01
CD 8 (cells/μl) 608±20 328±19 0.001
CD 19 (cells/μl) 234±8 214±13 NS
CD4/CD8 2.12±0.08 3.55±0.22 0.001
aMean ± SE
Table 4 Proportions (%) and numbers (per μl) of T and B cell
subsets in 66-year-old CMV-IgG positive and negative individ-
uals with CD4/CD8 ratio less than 1
Cell Subset CMV-IgG p<
Positive Negative
n056 n06
CD3 (%) 75.9±1.2a 80.1±3.3 NS
CD4 (%) 30.3±0.7 33.4±1.5 NS
CD8 (%) 40.7±2.1 40.2±2.7 NS
CD19 (%) 8.7±0.8 6.6±0.9 NS
CD3 (cells/μl) 2,052±93 1,702±58 0.01
CD4 (cells/μl) 817±40 710±26 0.05
CD8 (cells/μl) 1,108±59 852±47 0.01
CD19 (cells/μl) 221±20 139±18 NS
CD4/CD8 0.77±0.02 0.85±0.05 NS
aMean ± SE
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CD8 ratio less than 1 was significantly higher than
in those with a CD4/CD8 ratio greater than 1 (Table 5).
For CMV-IgG positive individuals from the entire
HEXA-2 sample, the percentage of TEMRA cells
were significantly higher than in CMV-IgG nega-
tive individuals. The latter individuals also showed
a significantly higher proportion of naïve cells.
Individuals with a CD4/CD8 ratio less than 1
and those who were CMV-IgG positive showed
significantly higher percentages of TEMRA cells
compared to those who were CMV-IgG negative.
Proportions (%) and numbers (per ul) of T and B cell
subsets, the CD4/CD8 ratio and CMV-IgG and IgM
status by gender in HEXA-2 individuals
Females showed significantly higher percentages and
numbers of CD3+CD4+ and CD19+ cells as well as
numbers of CD3+ cells compared to males (Table 6). A
CD4/CD8 ratio less than 1 was more common in males,
although females showed a higher prevalence of CMV-
IgG antibodies (NS).
Discussion
We investigated T and B cell subsets as well as CMV
status in a 66-year-old Swedish population-based sample
with a CD4/CD8 ratio less/greater than 1. The present
study demonstrates that individuals with an inverted
CD4/CD8 ratio reveal an immune profile consisting of
high CD8 and low CD4 and CD19 percentages, associ-
ated with seropositivity to CMVas well as to significant
increases in the number of lately differentiated CD8
+CD28− cells. An IRP associated with increased mor-
tality, consisting of high CD8 and low CD4 and CD19
percentages and poor proliferative response to ConA,
was initially identified using a cluster analysis approach
in octogenarian individuals participating in the Swedish
OCTO Immune study (Ferguson et al. 1995). Subse-
quent studies of very old individuals participating in
the Swedish OCTO and NONA immune studies indicat-
ed that this IRP could be defined using only the inverted
CD4/CD8 ratio (Wikby et al. 1998, 2002). These find-
ings were supported by a study showing that an inverted
CD4/CD8 ratio predicted survival in a U.K. sample of
elderly people (Huppert et al. 2003). Further, the pres-
ence of an inverted CD4/CD8 ratio in individuals above
the age of 60 was also confirmed in the KRIS study of
Swedish individuals in the age range of 20–79 years
(Wikby et al. 2008). Strikingly, all these studies did show
a prevalence of old individuals with an inverted CD4/
CD8 ratio of 16 % which is close to the finding of 15 %
in the present HEXA study. Thus, our findings demon-
strate that 66-year-old individuals show an immune pro-
file previously identified in the very old to be an IRP. It
will be important to follow up immune system changes
as well as clinical outcomes of these HEXA individuals
to establish if the immune profile has the same relevance
in younger old compared with older old individuals.
Table 5 The proportions (%) of naïve and terminally differen-
tiated effector memory CD45RA+ T cells (TEMRA) among
CD3+CD8+ cells in CD4/CD8 and CMV-IgG subgroups in
HEXA 2 individuals
Subgroup TEMRA (%) p< Naïve (%) p<
CD4/CD8 (entire group)
<1 (n050) 43.2±2.6a 0.001 6.4±1.1 0.001
>1 (n0101) 22.9±1.5 16.2±1.2
CMV-IgG (entire group)
Positive (n0118) 34.7±1.6 0.001 10.8±1.0 0.001
Negative (n031) 12.0±1.6 20.0±2.1
CMV-IgG (CD4/CD8 <1 individuals)
Positive (n046) 45.0±2.6 0.05 5.9±1.2 NS
Negative (n04) 22.6±5.5 12.3±4.3
aMean ± SE
Table 6 Proportions (%) and numbers of T and B cell subsets
and the prevalence of individuals with inverted CD4/CD8 ratio
and CMV carrier status by gender in 66-year-old individuals
Variable Male Female p<
n0197 n0227
CD3 (%) 71.6±0.7a 72.7±0.6 NS
CD4 (%) 42.9±0.7 45.4±0.6 0.05
CD8 (%) 21.4±0.8 23.2±0.6 NS
CD19 (%) 9.5±0.3 11.1±0.3 0.01
CD3 (cells/μl) 1,523±39 1,689±38 0.01
CD4 (cells/μl) 891±22 1,048±25 0.001
CD8 (cells/μl) 536±27 550±21 NS
CD19 (cells/μl) 198±8 257±10 0.001
CD4/CD8 <1 (%) 18.8 11.0 0.05
CMV-IgG (%) 73.1 80.6 NS
CMV-IgM (%) 5.6 5.7 NS
aMean ± SE
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The present study also identified changes with in-
creased levels of terminally differentiated CD8+ cells
with a CD3+CD8+CD27−CD28−CD45RA+CCR7
−perforin+phenotype (TEMRA) and a depletion of the
proportion of CD8+CCR7+CD45RA+naïve cells to be
associated with an inverted CD4/CD8 ratio along with
IgG seropositivity to CMV. These results suggest that
CMV might be a driving force in the generation of
TEMRA CD8+ cells also in this age group. Evidence
for a major impact of CMV in generating lately differ-
entiated CD8+ cells was earlier demonstrated in the
OCTO subjects by tetramer technology (Ouyang et al.
2003) and was also confirmed in the subsequent NONA
immune study in very old individuals (Reker-Hadrup et
al. 2006). Evidence has also been given that CD8
+CD28− cells possess the characteristics of replicative
senescence, including telomere shortening and
apoptosis-resistance (Spaulding et al. 1999; Effros
2007). In addition, T cell-mediated immunity appears
to be particularly susceptible to aging by a decrease in
the number and diversity of naïve T cells dramatically
decreased with the age-related thymic involution (Lang
et al. 2011). These naïve cells have been reported to
exhibit functional defects, including significantly
shorter telomeres, a restricted receptor repertoire, re-
duced IL-2 production, and impaired differentiation into
effector T cells (Lang et al. 2011). Consequently, their
ability to mediate effective immune responses against
new antigens might be decreased (Aspinall et al. 2010).
The changes found in the T cell system of the present
study therefore suggest that inversion of CD4/CD8 ratio
is a marker of immunosenescence.
In our previous KRIS study (Wikby et al. 2008), we
included data from a population-based sample in the
age range of 20–79 years to examine the prevalence of
individuals with an inverted CD4/CD8 ratio relative to
age and gender. The percentage of individuals with an
inverted CD4/CD8 ratio increased from about 8 % in
the age range of 20–59 years to about 16 % in the age
range of 60–94 and showed that the proportion of
individuals with an inverted ratio was significantly
higher in men whereas the numbers of CD3+CD4+
cells were found to be significantly higher in women,
regardless of age, indicating that genetic or thymic
factors, or both, might be of importance in balancing
the relative numbers of CD3+CD4+ and CD3+CD8+ T
cells in the individual. Interestingly, these data are
strikingly similar to those found in the present study
and are close to those presented by Amadori et al.
(1995) and Clementi et al. (1999). The latter studies
indicated that within a population of healthy blood
donors, the CD4/CD8 ratio varies; with 5 % of indi-
viduals having values less than 1 and that as much as
57 % of the variation is under genetic control (Amadori
et al. 1995). In the HEXA study, this would correspond
to a finding of 21 individuals with an inverted CD4/
CD8 ratio and since the prevalence of persistent CMV
infection is 77 %, we would expect to find 16 of these
21 individuals to be CMV positive whereas five indi-
viduals would be CMV negative by random. This is in
sharp contrast to the actual finding of 62 individuals
with an inverted CD4/CD8 ratio, i.e., almost three
times higher prevalence, with 56 being CMV positive
and six being negative. Since the finding of six CMV
negative individuals is close to what would be
expected from a genetic point of view, it is plausible
that an inverted CD4/CD8 ratio in these individuals is
associated with genetic factors. This notion is also
supported by the findings that CMV negative individ-
uals with an inverted CD4/CD8 ratio did not show any
T cell changes associated with CMV, while those being
positive did. Our findings of 56 CMV-IgG positive
individuals with an inverted CD4/CD8 ratio, however,
seem to be far too many to be explained only by means
of a normal genetic distribution. Instead, it seems plau-
sible that a majority of these individuals have moved
into the <1 category by decreases in their CD4/CD8
ratio. CMV infection seems to have had a major impact
on recruiting additional individuals into this category
by the generation of CD3+CD8+CD28− cell expan-
sions, changes that we also identified previously in the
very old (Wikby et al. 1998). Increases in the number
of individuals being IgM seropositive as well as sig-
nificant increases in the CMV-IgG antibody levels in
individuals with a CD4/CD8 ratio less than 1 support
the hypothesis that these expansions might be due to
increased CMV reactivation and replication (Stowe et
al. 2007). The clinical relevance in the measurement of
CMV-IgG antibody levels in studies of immune system
and aging was recently demonstrated by findings sup-
porting an independent association between CMV IgG
antibody level and 7-year mortality in community-
living older adults (Strandberg et al. 2009). CMV was
also associated with a significant increased risk for all-
cause mortality in a U.S. nationally representative
study (Simanek et al. 2011). The present study also
supports that the changes described become important
by the age of 65 (Saule et al. 2006; Wikby et al. 2008).
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In conclusion, the results indicate that the immune
profile, previously shown in octo- and nonagenerians
to be associated with increased mortality (an IRP),
also exists in the present sample of hexagenerians.
Therefore, it will be important to examine morbidity
and mortality to assess whether the profile also is a
risk profile in this sample (an IRP) of hexagenerians.
Acknowledgments The authors acknowledge the consider-
able support of FUTURUM—the academy of healthcare, Coun-
ty Council, Jönköping and the Medical Research Council of
South-East Sweden for funding this project. We are also grateful
to Anette Bower Nilsson, Ryhov Count Hospital, Jönköping for
excellent technical support.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the
original author(s) and the source are credited.
References
Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G,
Danieli GA, Clementi M, Chieco-Bianchi L (1995) Genetic
control of the CD4/CD8 T cell ratio in humans. Nat Med 1
(12):1279–1283
Aspinall R, Pitts D, Lapenna A, Mitchell WA (2010) Immunity
in the elderly: the role of the thymus. J Comp Pathol 142:
S111–S115
Clementi M, Forabosco P, Amadori A, Zamarchi R, De Silvestro
G, Di Gianantonio E, Chieco-Bianchi L, Tenconi R (1999)
CD4 and CD8 T lymphocyte inheritance. Evidence for major
autosomal recessive genes. Hum Genet 105:337–342
Effros RB (2007) Telomerase induction in T cells: a cure for
aging and disease? Exp Gerontol 42(5):416–420
Ferguson F, Wikby A, Maxson P, Olsson J, Johansson B (1995)
Immune parameters in a longitudinal study of a very old
population of Swedish people: a comparison between sur-
vivors and nonsurvivors. J Gerontol Biol Sci 50A:B378–
B382
Huppert FA, Pinto EM, Morgan K, Brayne C (2003) Survival in
a population sample is predicted by proportions of lym-
phocyte subsets. Mech Ageing Dev 124:449–451
Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA (2011)
Immunosenescence: implications for vaccination pro-
grammes in adults. Maturitas 68:322–330
Nilsson BO, Ernerudh J, Johansson B, Evrin PE, Löfgren S,
Ferguson F, Wikby A (2003) Morbidity does not influence
the T cell immune risk phenotype in the elderly: findings in
the Swedish NONA immune study using sample selection
protocols. Mech Ageing Dev 124:469–476
Olsson J, Wikby A, Johannson B, Löfgren S, Nilsson BO,
Ferguson F (2000) Age-related change in peripheral blood
T-lymphocyte subpopulations and cytomegalovirus infec-
tion in very old: Swedish longitudinal OCTO immune
study. Mech Ageing Dev 121:187–201
Ouyang Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi
AI, Travers P, Pawelec G (2003) Large numbers of dys-
functional CD8+ T-lymphocytes bearing receptors for a
single dominant CMV epitope in the very old. J Clin
Immunol 23:247–257
Pawelec G, Ferguson F, Wikby A (2001) The SENIEUR proto-
col after 16 years. Mech Ageing Dev 122:132–134
Pawelec G, Larbi A, Derhovanessian E (2010) Senescence of
the human immune system. J Comp Pathol 142:39–44
Reker-Hadrup S, Strindhall J, Kollgaard T, Seremet T, Johannson
B, Pawelec G, thor Straten P, Wikby A (2006) Longitudinal
studies of clonally expanded CD8 T cells reveal a repertoire
shrinkage predicting mortality and increased number of dys-
functional cytomegalovirus-specific T cells in the elderly. J
Immunol 176:2645–2653
Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint JP, Labalette M
(2006) Accumulation of memory T cells from childhood to
old age: central and effector memory cells in CD4(+)
versus effector memory and terminally differentiated mem-
ory cells in CD8(+) compartment. Mec Ageing Dev
127:274–281
Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello
AE (2011) Seropositivity to cytomegalovirus, inflamma-
tion, all-cause and cardiovascular disease-related mortality
in United States. PLoS One 6(2):e16103
Spaulding CS, Guo W, Effros RB (1999) Resistance to apopto-
sis in human CD8+ T cells that reach replicative senes-
cence after multiple rounds of antigen-specific
proliferation. Exp Gerontol 34:633–644
Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS,
Glaser R (2007) Chronic herpes virus reactivation occurs in
aging. Exp Gerontol 42:563–570
Strandberg TE, Pitkala KH, Tilvis RS (2009) Cytomegalovirus
antibody level and mortality among community-dwelling
older adults with stable cardiovascular disease. JAMA 301
(4):380–382
Wikby A, Maxson P, Olsson J, Johansson B, Ferguson F (1998)
Changes in CD8 and CD4 lymphocyte subsets, T cell
proliferation responses and non-survival in the very old:
the Swedish longitudinal OCTO-immune study. Mech
Ageing Dev 102:187–198
Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson BO,
Ferguson F (2002) Expansions of peripheral blood CD8
T-lymphocyte subpopulations and an association with cy-
tomegalovirus seropositivity in the elderly: the Swedish
NONA immune study. Exp Gerontol 37:445–453
Wikby A, Månsson I, Johansson B, Strindhall J, Nilsson SE
(2008) The immune risk profile is associated with age and
gender: findings from three Swedish population studies
of individuals 200–100 years of age. Biogerontology
9:299–308
AGE (2013) 35:985–991 991
